Eli Lilly and Company LLY is a leader in the fast-growing diabetes and obesity market, driven by its blockbuster ...

Eli Lilly is set to launch Lormalzi, a groundbreaking monthly injection targeting amyloid plaques for Alzheimer's treatment, ...

The prescription-only drug, Lormalzi can help the body remove the excessive buildup of amyloid plaques and slow the decline ...

Eli Lilly introduces Lormalzi in India, a new Alzheimer's therapy targeting amyloid plaques. Priced at Rs 91,688 per month.

Eli Lilly and Novo Nordisk are building cases for their incretin drugs both new and old as attractive weight loss maintenance ...